179 related articles for article (PubMed ID: 21295172)
1. Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study).
Jiang W; Krishnan R; Kuchibhatla M; Cuffe MS; Martsberger C; Arias RM; O'Connor CM;
Am J Cardiol; 2011 Feb; 107(4):545-51. PubMed ID: 21295172
[TBL] [Abstract][Full Text] [Related]
2. Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.
Xiong GL; Fiuzat M; Kuchibhatla M; Krishnan R; O'Connor CM; Jiang W;
Circ Heart Fail; 2012 Nov; 5(6):688-92. PubMed ID: 23065038
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.
O'Connor CM; Jiang W; Kuchibhatla M; Silva SG; Cuffe MS; Callwood DD; Zakhary B; Stough WG; Arias RM; Rivelli SK; Krishnan R;
J Am Coll Cardiol; 2010 Aug; 56(9):692-9. PubMed ID: 20723799
[TBL] [Abstract][Full Text] [Related]
4. Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.
Kuchibhatla MN; Fillenbaum GG
Am J Geriatr Pharmacother; 2011 Dec; 9(6):483-94. PubMed ID: 22035643
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
Jiang W; O'Connor C; Silva SG; Kuchibhatla M; Cuffe MS; Callwood DD; Zakhary B; Henke E; Arias RM; Krishnan R;
Am Heart J; 2008 Sep; 156(3):437-44. PubMed ID: 18760123
[TBL] [Abstract][Full Text] [Related]
6. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
7. Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
Flynn Longmire CV; Drye LT; Frangakis CE; Martin BK; Meinert CL; Mintzer JE; Munro CA; Porsteinsson AP; Rabins PV; Rosenberg PB; Schneider LS; Weintraub D; Lyketsos CG;
Am J Geriatr Psychiatry; 2014 Jan; 22(1):14-24. PubMed ID: 24314887
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants.
Glassman AH; Bigger JT; Gaffney M
Arch Gen Psychiatry; 2009 Sep; 66(9):1022-9. PubMed ID: 19736359
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
10. Clinical differences between early and late remission in depressive patients.
Roca M; García-Toro M; García-Campayo J; Vives M; Armengol S; García-García M; Asensio D; Gili M
J Affect Disord; 2011 Nov; 134(1-3):235-41. PubMed ID: 21676465
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.
Wiethoff K; Bauer M; Baghai TC; Möller HJ; Fisher R; Hollinde D; Kiermeir J; Hauth I; Laux G; Cordes J; Brieger P; Kronmüller KT; Zeiler J; Adli M
J Clin Psychiatry; 2010 Aug; 71(8):1047-54. PubMed ID: 20673545
[TBL] [Abstract][Full Text] [Related]
12. Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study.
Michalakeas CA; Parissis JT; Douzenis A; Nikolaou M; Varounis C; Andreadou I; Antonellos N; Markantonis-Kiroudis S; Paraskevaidis I; Ikonomidis I; Lykouras E; Kremastinos D
J Card Fail; 2011 Sep; 17(9):748-54. PubMed ID: 21872145
[TBL] [Abstract][Full Text] [Related]
13. Validity of Beck Depression Inventory for the assessment of depressive mood in chronic heart failure patients.
Lahlou-Laforêt K; Ledru F; Niarra R; Consoli SM;
J Affect Disord; 2015 Sep; 184():256-60. PubMed ID: 26118753
[TBL] [Abstract][Full Text] [Related]
14. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
Barrett JE; Williams JW; Oxman TE; Frank E; Katon W; Sullivan M; Hegel MT; Cornell JE; Sengupta AS
J Fam Pract; 2001 May; 50(5):405-12. PubMed ID: 11350703
[TBL] [Abstract][Full Text] [Related]
15. Depression outcome in inpatients with congestive heart failure.
Koenig HG
Arch Intern Med; 2006 May; 166(9):991-6. PubMed ID: 16682572
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
[TBL] [Abstract][Full Text] [Related]
17. Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations.
Troxel WM; Kupfer DJ; Reynolds CF; Frank E; Thase ME; Miewald JM; Buysse DJ
J Clin Psychiatry; 2012 Apr; 73(4):478-85. PubMed ID: 22152403
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
[TBL] [Abstract][Full Text] [Related]
19. One-year change in anterior cingulate cortex white matter microstructure: relationship with late-life depression outcomes.
Taylor WD; Macfall JR; Boyd B; Payne ME; Sheline YI; Krishnan RR; Murali Doraiswamy P
Am J Geriatr Psychiatry; 2011 Jan; 19(1):43-52. PubMed ID: 20808126
[TBL] [Abstract][Full Text] [Related]
20. Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).
Østergaard SD; Rothschild AJ; Flint AJ; Mulsant BH; Whyte EM; Vermeulen T; Bech P; Meyers BS
J Affect Disord; 2016 Jan; 190():111-114. PubMed ID: 26496016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
